Skip to main content Skip to footer
Immunic Therapeutics
  • Home
  • About
    • About
    • Management
    • Board of Directors
    • Scientific-Medical
      Advisory Board
    • Company Values
  • Pipeline
    • Pipeline
    • Vidofludimus Calcium
    • IMU-856
    • IMU-381
  • News
    • News Releases
    • Photo Corner
    • Video Corner
  • Publications
  • Investors
    • IR Home
    • News Releases
    • Events and Presentations
    • Stock Information
    • Financials and SEC Filings
    • Corporate Governance
    • IR Contact
  • Career
  • Contact
  • Home
  • About
    • About
    • Management
    • Board of Directors
    • Scientific-Medical
      Advisory Board
    • Company Values
  • Pipeline
    • Pipeline
    • Vidofludimus Calcium
    • IMU-856
    • IMU-381
  • News
    • News Releases
    • Photo Corner
    • Video Corner
  • Publications
  • Investors
    • IR Home
    • News Releases
    • Events and Presentations
    • Stock Information
    • Financials and SEC Filings
    • Corporate Governance
    • IR Contact
  • Career
  • Contact
Scroll to top
Immunic Therapeutics

Immunic, Inc.

1200 Avenue of the Americas
Suite 200
New York, NY 10036, USA

Phone: +1 332 2559811
Email: info@imux.com

Immunic AG

Lochhamer Schlag 21
82166 Gräfelfing
Germany

Phone: +49 89 2080 477 00
Email: info@imux.com

Contact Us

Help for patients from Ukraine and Lebanon

Допомога пацієнтам з України та Лівану

مساعدة للمرضى من أوكرانيا ولبنان

  • About
  • Pipeline
  • Vidofludimus Calcium
  • IMU-856
  • IMU-381
  • News
  • Publications
  • Investors
  • Career
  • Contact
  • Legal Notice / Impressum
  • Accessibility Statement
  • Privacy Policy / Datenschutz
© 2026, Immunic Therapeutics
All rights reserved.
  • Home – 2
  • About
  • Pipeline
  • News
  • Publications
  • Investors
  • Career
  • Contact
  • Management
  • Board of Directors
  • Scientific-Medical
    Advisory Board
  • Company Values
  • Vidofludimus Calcium
  • IMU-856
  • IMU-381
  • IR Home
  • News Releases
  • Events and Presentations
  • Stock Informations
  • Financials and SEC Filings
  • Corporate Governance
  • IR Contact